KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Equity (2016 - 2025)

AbbVie (ABBV) has disclosed Return on Equity for 13 consecutive years, with 1.44% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 235.0% to 1.44% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.44% through Dec 2025, down 235.0% year-over-year, with the annual reading at 87.28% for FY2025, 8665.0% up from the prior year.
  • Return on Equity for Q4 2025 was 1.44% at AbbVie, up from 1.72% in the prior quarter.
  • The five-year high for Return on Equity was 5.7% in Q2 2025, with the low at 1.72% in Q3 2025.
  • Average Return on Equity over 5 years is 0.74%, with a median of 0.68% recorded in 2024.
  • Peak annual rise in Return on Equity hit 498bps in 2025, while the deepest fall reached -252bps in 2025.
  • Over 5 years, Return on Equity stood at 0.8% in 2021, then dropped by -11bps to 0.71% in 2022, then crashed by -43bps to 0.4% in 2023, then surged by 127bps to 0.91% in 2024, then plummeted by -258bps to 1.44% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.44%, 1.72%, and 5.7% for Q4 2025, Q3 2025, and Q2 2025 respectively.